Counterfeit drugs and devices reach the United States every day. Here are the risks involved and steps to mitigate the impact of counterfeit pharmaceuticals.
Counterfeit drugs have long been rife in developing countries, where regulations are lax and supply chains are harder to track. But in recent years, as the pharmaceutical supply chain has expanded globally, drugs and devices headed for the US are more susceptible to tampering and fraud.
Take a look at our latest infographic, which covers the risks involved with counterfeits in pharmaceuticals. We also include best practices when it comes to mitigating those risks and keeping harmful reproductions out of your supply chain.
By Amy Clark - July 10, 2015
This Sunday, July 12th, will mark what some consider to be the most important moment in the European Union’s history: the Eurozone leader meeting that will determine whether or not a “Grexit” is necessary. As analysts debate the likelihood of a...Read more
By Mary De Asis - October 10, 2018